Behnood Bikdeli1,2,3, David Jiménez4,5,6. 1. Cardiovascular Medicine Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States. 2. Center for Outcomes Research and Evaluation (CORE), Yale University School of Medicine, New Haven, United States. 3. Cardiovascular Research Foundation (CRF), New York, United States. 4. Respiratory Department, Ramón y Cajal Hospital, IRYCIS, Madrid, Spain. 5. Medicine Department, Universidad de Alcala, IRYCIS, Madrid, Spain. 6. CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain.
Authors: Rodrigo Abensur Athanazio; José Manuel Ceresetto; Luis Javier Marfil Rivera; Gabriela Cesarman-Maus; Kenny Galvez; Marcos Arêas Marques; Aldo Hugo Tabares; Carlos Alberto Ortiz Santacruz; Fernando Costa Santini; Luis Corrales; Alexander T Cohen Journal: Clin Appl Thromb Hemost Date: 2022 Jan-Dec Impact factor: 2.389